AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt–MDM2–Foxo3a Signaling Axis
- Type
- Correction
- Notice date
- 6/14/2018 0:00
- Journal
- Cancer Research
- Publisher
- American Association for Cancer Research
- Notice DOI
- 10.1158/0008-5472.can-18-0559
- Original paper DOI
- 10.1158/0008-5472.can-14-0135
Reasons
- Concerns/Issues about Image
- Investigation by Company/Institution
- Misconduct - Official Investigation(s) and/or Finding(s)
- Misconduct by Author